Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Furgan Aslanoglu & Ahmet Yazıcı. (2023) 6-methylthiouracil and 6-methyluracil derivatives synthesized by reaction of acetylketene with thiourea and urea compounds in presence of Yb(TFA)3. Synthetic Communications 53:20, pages 1713-1721.
Read now
Read now
Eleftherios Teperikidis, Aristi Boulmpou, Panagiotis Charalampidis, Chalil Tsavousoglou, George Giannakoulas, Christodoulos E. Papadopoulos & Vassilios Vassilikos. (2022) 5-Fluorouracil, capecitabine and vasospasm: a scoping review of pathogenesis, management options and future research considerations. Acta Cardiologica 77:1, pages 1-13.
Read now
Read now
Articles from other publishers (19)
Muhtada A Challoob & Nawar S Mohammed. (2023) The Evaluation of Dihydropyrimidine Dehydrogenase Enzyme Level in the Serum of Colorectal Cancer Iraqi Males on Fluoropyrimidine-Based Chemotherapy (Capecitabine). Cureus.
Crossref
Crossref
Yuan Fang, XiaoLi Zhang, HanFei Huang & Zhong Zeng. (2023) The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. Journal of Translational Medicine 21:1.
Crossref
Crossref
Maria V. Guijarro, Patrick C. Kellish, Peter E. Dib, Nicholas G. Paciaroni, Akbar Nawab, Jacob Andring, Lidia Kulemina, Nicholas V. Borrero, Carlos Modenutti, Michael Feely, Elham Nasri, Robert P. Seifert, Xiaoping Luo, Richard L. Bennett, Daniil Shabashvili, Jonathan D. Licht, Robert McKenna, Adrian Roitberg, Robert W. HuigensIIIIII, Frederic J. Kaye & Maria Zajac-Kaye. (2023) First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival. JCI Insight 8:10.
Crossref
Crossref
Xingxing Xu, Zixuan Li, Xueying Yao, Nannan Sun & Junbiao Chang. (2023) Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Shiqi Nong, Xiaoyue Han, Yu Xiang, Yuran Qian, Yuhao Wei, Tingyue Zhang, Keyue Tian, Kai Shen, Jing Yang & Xuelei Ma. (2023) Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm 4:2.
Crossref
Crossref
Xiang Chen, Danna Liang, Weijian Sun, Xin Shou, Luoran Shang & Xian Shen. (2023) Suspended bubble microcapsule delivery systems from droplet microfluidic technology for the local treatment of gastric cancer. Chemical Engineering Journal 458, pages 141428.
Crossref
Crossref
Sai Zhang, Shunli Fan, Zhenglu Wang, Wen Hou, Tao Liu, Sei Yoshida, Shuang Yang, Hong Zheng & Zhongyang Shen. (2022) Capecitabine Regulates HSP90AB1 Expression and Induces Apoptosis via Akt/SMARCC1/AP-1/ROS Axis in T Cells. Oxidative Medicine and Cellular Longevity 2022, pages 1-15.
Crossref
Crossref
A. S. Chiriapkin. (2022) REVIEW OF PYRIMIDINE DERIVATIVES AS PHARMACOLOGICALLY ACTIVE COMPOUNDS. Juvenis Scientia 8:5, pages 16-30.
Crossref
Crossref
Anshoo Gautam & Lipsy Goyal. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1183
1204
.
Anshoo Gautam & Lipsy Goyal. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
22
.
Guoqing Ouyang, Yongrong Wu, Zhen Liu, Wuchang Lu, Shuai Li, Shuqing Hao & Guangdong Pan. (2021) Efficacy and safety of gemcitabine-capecitabine combination therapy for pancreatic cancer. Medicine 100:48, pages e27870.
Crossref
Crossref
Ying Gao, Zhe Liu & Yiting Liu. (2021) Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects. World Journal of Surgical Oncology 19:1.
Crossref
Crossref
Olga Michalak, Piotr Cmoch, Andrzej Leś, Marcin Cybulski, Piotr Krzeczyński, Kinga Trzcińska, Przemysław Miszta, Pakhuri Mehta & Sławomir Filipek. (2021) Unexpected Reaction Products of Uracil and Its Methyl Derivatives with Acetic Anhydride and Methylene Chloride. The Journal of Organic Chemistry 86:21, pages 14321-14332.
Crossref
Crossref
Jaihyung Lee, Yi-Xi Gong, Hyunjeong Jeong, Hoyoung Seo, Dan-Ping Xie, Hu-Nan Sun & Taeho Kwon. (2021)
Pharmacological effects of
Picrasma quassioides
(D. Don) Benn for inflammation, cancer and neuroprotection (Review)
. Experimental and Therapeutic Medicine 22:6.
Crossref
Crossref
Chelsea Schiliro & Bonnie L. Firestein. (2021) Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation. Cells 10:5, pages 1056.
Crossref
Crossref
Milad Baroud, Elise Lepeltier, Sylvain Thepot, Yolla El-Makhour & Olivier Duval. (2021) The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery. Nanoscale Advances 3:8, pages 2157-2179.
Crossref
Crossref
David M. Peereboom, Tyler J. Alban, Matthew M. Grabowski, Alvaro G. Alvarado, Balint Otvos, Defne Bayik, Gustavo Roversi, Mary McGraw, Pengjing Huang, Alireza M. Mohammadi, Harley I. Kornblum, Tomas Radivoyevitch, Manmeet S. Ahluwalia, Michael A. Vogelbaum & Justin D. Lathia. (2019) Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells. JCI Insight 4:22.
Crossref
Crossref
Ran Zhang, Xue-Qing Song, Rui-Ping Liu, Zhong-Ying Ma & Jing-Yuan Xu. (2019) Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. Journal of Medicinal Chemistry 62:9, pages 4543-4554.
Crossref
Crossref
Yuanjun Shen, Zhanquan Shi & Bingfang Yan. (2019) Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and other Transcription Factors. Nuclear Receptor Research 6.
Crossref
Crossref